Search results
Results from the WOW.Com Content Network
The primary outcome of the VEST-study, arrhythmic mortality, was 1.6% in the WCD group vs. 2.4% in the control group. The difference was not significant despite a 33% relative risk reduction (RRR). The secondary outcome of the VEST-study, all-cause mortality, was 3.1% in the WCD group and 4.9% in the control group.
Phone support is available for account management and password reset help, Mon-Fri: 8am-12am ET; Sat: 8am-10pm ET. For additional hours of operation for different services visit our support options page for contact info.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Paul Maurice Zoll (July 15, 1911 – January 5, 1999) [1] was a Jewish [2] American cardiologist and one of the pioneers in the development of the artificial cardiac pacemaker and cardiac defibrillator.
The AutoPulse is an automated, portable, battery-powered cardiopulmonary resuscitation device created by Revivant and subsequently purchased and currently manufactured by ZOLL Medical Corporation. It is a chest compression device composed of a constricting band and half backboard that is intended to be used as an adjunct to CPR during advanced ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us